Loading...
Is human hepatocellular carcinoma a hormone-responsive tumor?
Before the positive results recently obtained with multitarget tyrosine kinase inhibitor sorafenib, there was no standard systemic treatment for patients with advanced hepatocellular carcinoma (HCC). Sex hormones receptors are expressed in a significant proportion of HCC samples. Following preclinic...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
The WJG Press and Baishideng
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2695908/ https://ncbi.nlm.nih.gov/pubmed/18350599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.1682 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|